Passage BIO PASG
NASDAQ PASG
$4.12 -0.20 (-4.63%)
At close: Oct 2, 2026 · 4:00 PM EDT

Passage BIO (PASG) Asset Writedowns and Impairment (2023 - 2025)

Updated

Passage BIO (PASG) reported Asset Writedowns and Impairment of $3.51 million for Q4 2025.

Analysis

Passage BIO (PASG) Asset Writedowns and Impairment (2023 - 2025) Analysis & Trends

For FY2025, Passage BIO posted Asset Writedowns and Impairment of $6.15 million, up 17.4% from FY2024.

  • By year, Asset Writedowns and Impairment came in at $5.23 million in FY2024 (-2.9%) and $5.39 million in FY2023.
  • The Q4 2025 figure ranks as the highest quarterly Asset Writedowns and Impairment since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Passage BIO 13.26 Mn 13.26 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.51 Mn
Mar 31, 2025 2.64 Mn
Sep 30, 2024 4.80 Mn
Jun 30, 2024 438,000.00
Sep 30, 2023 5.39 Mn
API Access

Passage BIO Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=PASG&period=max&api_key=YOUR_API_KEY